Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Valvular Heart Disease

Free Subscription Articles published in Mayo Clin Proc Retrieve available abstracts of 15 articles: HTML format Text format

Single Articles

July 2019
1. RUBIN J, Aggarwal SR, Swett KR, Kirtane AJ, et al
   Burden of Valvular Heart Diseases in Hispanic/Latino Individuals in the United States: The Echocardiographic Study of Latinos.
   Mayo Clin Proc. 2019 Jul 3. pii: S0025-6196(19)30129.
   PubMed     Text format     Abstract available
   
   
   
2. FENDER EA, Petrescu I, Ionescu F, Zack CJ, et al
   Prognostic Importance and Predictors of Survival in Isolated Tricuspid Regurgitation: A Growing Problem.
   Mayo Clin Proc. 2019 Jul 3. pii: S0025-6196(19)30467.
   PubMed     Text format     Abstract available
   
   
   
3. YANG LT, Michelena HI, Maleszewski JJ, Schaff HV, et al
   Contemporary Etiologies, Mechanisms, and Surgical Approaches in Pure Native Aortic Regurgitation.
   Mayo Clin Proc. 2019;94:1158-1170.
   PubMed     Text format     Abstract available
   
   
   
4. LUIS SA, Padang R, Murphy JG
   Isolated Aortic Regurgitation: A Tale of Two Disorders.
   Mayo Clin Proc. 2019;94:1131-1134.
   PubMed     Text format    
   
   
   May 2019
5. INGLES J, Semsarian C
   An Unexpected FLNC Phenotype: Expanding the Clinical Spectrum or a Second-Hit Disease Mechanism?
   Mayo Clin Proc. 2019;94:751-753.
   PubMed     Text format    
   
   
   April 2019
6. AL-HIJJI M, Narula N, Go JL, Khosla S, et al
   Circulating Osteogenic Progenitor Cells in Mild, Moderate, and Severe Aortic Valve Stenosis.
   Mayo Clin Proc. 2019;94:652-659.
   PubMed     Text format     Abstract available
   
   
   
7. BOSTROM KI
   The Shifting Nature of Endothelial Progenitor Cells in Aortic Stenosis.
   Mayo Clin Proc. 2019;94:567-569.
   PubMed     Text format    
   
   
   March 2019
8. BAINS S, Tester DJ, Asirvatham SJ, Noseworthy PA, et al
   A Novel Truncating Variant in FLNC-Encoded Filamin C May Serve as a Proarrhythmic Genetic Substrate for Arrhythmogenic Bileaflet Mitral Valve Prolapse Syndrome.
   Mayo Clin Proc. 2019 Mar 29. pii: S0025-6196(18)30984.
   PubMed     Text format     Abstract available
   
   
   February 2019
9. NAVARESE EP, Andreotti F, Kolodziejczak M, Wanha W, et al
   Age-Related 2-Year Mortality After Transcatheter Aortic Valve Replacement: the Young TAVR Registry.
   Mayo Clin Proc. 2019 Feb 26. pii: S0025-6196(19)30044.
   PubMed     Text format     Abstract available
   
   
   
10. BHATIA S, Sims JR, Anavekar NS
    75-Year-Old Man With Chest Pain and Dyspnea.
    Mayo Clin Proc. 2019;94:341-346.
    PubMed     Text format    
    
    
    January 2019
11. BUSHARI LI, Reeder GS, Eleid MF, Chandrasekaran K, et al
    Percutaneous Transcatheter Edge-to-Edge MitraClip Technique: A Practical "Step-by-Step" 3-Dimensional Transesophageal Echocardiography Guide.
    Mayo Clin Proc. 2019;94:89-102.
    PubMed     Text format     Abstract available
    
    
    
12. HOLST KA, Hanson KT, Ommen SR, Nishimura RA, et al
    Septal Myectomy in Hypertrophic Cardiomyopathy: National Outcomes of Concomitant Mitral Surgery.
    Mayo Clin Proc. 2019;94:66-73.
    PubMed     Text format     Abstract available
    
    
    June 2018
13. SCHUPACK DA, Jansson-Knodell CL, Loftus CG
    44-Year-Old Man With Elevated Transaminases and Dyspnea on Exertion.
    Mayo Clin Proc. 2018;93:e59-e63.
    PubMed     Text format    
    
    
    April 2018
14. KANWAR A, Thaden JJ, Nkomo VT
    Management of Patients With Aortic Valve Stenosis.
    Mayo Clin Proc. 2018;93:488-508.
    PubMed     Text format     Abstract available
    
    
    March 2018
15. ALQAHTANI F, Aljohani S, Amin AH, Al-Hijji M, et al
    Effect of Race on the Incidence of Aortic Stenosis and Outcomes of Aortic Valve Replacement in the United States.
    Mayo Clin Proc. 2018 Mar 2. pii: S0025-6196(17)30880.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: